CIK 0001574235 · Non-accelerated filer<br>Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461821392
- Phone
- (888) 355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-16 | Sherman Matthew L Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | Munshi Amit Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | Raad Teofilo David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2019-05-16 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-05-16 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2018-06-05 | Roach James M. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +801,000 | 801,000 | ||
| 2018-06-05 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | ||
| 2018-06-05 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2018-06-05 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2018-06-05 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2018-06-05 | Raad Teofilo David Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +741,000 | 741,000 | ||
| 2018-06-05 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +795,000 | 795,000 | ||
| 2018-06-05 | Munshi Amit Director | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2018-06-05 | Sherman Matthew L Director | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2018-06-05 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +124,000 | 124,000 | ||
| 2018-06-05 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +850,000 | 850,000 | ||
| 2018-04-03 | GILLIS STEVEN Director | Purchase | +1,150,000 | 3,436,456 |
Page 4 of 8 · 154 trades